| Category | Frequency |
|---|---|
| Single-gene | 1/500 – 1/100 |
| Chromosomal | 0.5–0.7% |
| Multifactorial | 20–40% (most common) |
| Mitochondrial | Rare |
| Causes of malformations in affected infants | % |
|---|---|
| Unknown | 43.2 |
| Familial / multifactorial | 37.5 |
| Chromosomal | 10.1 |
| Teratogens | 3.2 |
| Single mutant genes | 3.1 |
| Uterine factors | 2.5 |
| Twinning | 0.4 |
Multifactorial conditions are the most common category (20–40%). Examples: oral clefts (1/500–1/1,500), NTDs (1/2,500), congenital heart defects (1/100), diabetes (1/10), schizophrenia (1/100).
| Etiology | MZ concordance | DZ concordance |
|---|---|---|
| Purely genetic | 100% | <100%, like ordinary siblings |
| Purely environmental | Equal in MZ and DZ | |
| Multifactorial | MZ > DZ, but MZ <100% | |
Oral cleft: MZ 35–40%, DZ 4–5% → not purely genetic (MZ <100%) and not purely environmental (MZ ≠ DZ) → multifactorial.
MZ twins aren't perfect genetic copies: post-split somatic mutations, epigenetics and X-inactivation make them differ.
| Family history | Lifetime DM2 risk |
|---|---|
| One parent affected | 40% |
| Both parents affected | 70% |
| First-degree relative | 3× the population risk |
| Twins | MZ ≈70%, DZ 20–30% |
Both parents with type 2 diabetes → ≈70% lifetime risk; lifestyle modification (exercise, weight loss) is the key intervention.
Each risk allele and each environmental exposure adds a cup of water to a bucket. Disease appears only when the bucket overflows (the threshold). Relatives start with a fuller bucket.
| Type | Defect | Outcome |
|---|---|---|
| Anencephaly | Brain fails to develop (cranial end) | Fatal |
| Encephalocele | Brain herniates through a skull defect | Rare, often fatal; ID and neuro deficits; consider a syndrome |
| Spina bifida occulta | Vertebral arch defect only | Mild (tuft of hair, dimple) |
| Meningocele | Meninges herniate | Milder |
| Myelomeningocele | Meninges + cord/nerves herniate | Paralysis, bladder/bowel, leg deformities |
Open NTDs → ↑ maternal serum AFP and ↑ amniotic AChE. Myelomeningocele often comes with Chiari II and hydrocephalus. Anencephaly → polyhydramnios (no swallowing).
| Who | Folic acid |
|---|---|
| All women of reproductive age | 0.4–0.8 mg/day (prevents up to 70% of NTDs; half of pregnancies are unplanned) |
| Prior affected pregnancy | 4 mg/day from ≥1 month before conception through the 1st trimester |
Diet low in folic acid, maternal obesity, excess alcohol and anticonvulsants (valproate, phenytoin, carbamazepine) are the tested NTD risk factors. MTHFR 677C>T → ↑ homocysteine.
Folic acid doses: "0.4 for everyone, 4 for the one who's had one."
Recurrence rises with each affected child (5% → 8%): a hallmark of multifactorial ("complex") inheritance that single-gene risks don't show.
Cleft lip = failed fusion of maxillary + medial nasal processes (primary palate). Cleft palate = failed fusion of the palatine shelves (secondary palate).
"Cleft + something else" or "NTD + something else" = look for a syndrome before quoting a multifactorial risk.
| Syndrome | Cause / inheritance | Key features | Recurrence |
|---|---|---|---|
| Fetal alcohol syndrome | Teratogen: alcohol | Growth retardation; microcephaly, short palpebral fissures, smooth philtrum, thin upper lip, hypertelorism; small 5th nails; cardiac/renal/eye; ID, ADHD, speech problems; can have spina bifida | Preventable; clinical diagnosis (history + exam, no genetic test) |
| Meckel-Gruber | AR (MKS1, TMEM67, CEP290, others; ciliopathy) | Encephalocele + CNS anomalies, polydactyly, polycystic kidneys, small eyes, oral cleft, poor survival | 25%; carrier testing both parents |
| Fetal hydantoin (Dilantin) | Teratogen: phenytoin | Growth retardation; hypertelorism, depressed nasal bridge, short nose, oral cleft; hypoplastic distal phalanges, small nails; learning/attention problems | Avoidable (drug choice) |
| van der Woude | AD, IRF6 (chr 1) | Lower lip pits + cleft lip ± palate + hypodontia; CHD, finger webbing; variable expressivity | 50% |
Cleft lip + mother with epilepsy on phenytoin → fetal hydantoin syndrome. Cleft + lower-lip pits across generations → van der Woude (IRF6, AD). Toddler with spina bifida, short palpebral fissures and thin philtrum → FAS (clinical diagnosis).
van der Woude shows variable expressivity (lip pits only vs full cleft) with high penetrance. Pits can hide on the inner lower lip; a "normal" relative may be affected.
Valproate → NTDs (spina bifida); carbamazepine → NTDs; phenytoin → fetal hydantoin; methotrexate → NTDs (antifolate). All anticonvulsant pregnancies get high-dose folic acid.
1Which category of genetic disease is most common in the population?
2A condition shows 38% concordance in MZ twins and 5% in DZ twins. Best interpretation?
3Why might monozygotic twins differ for a genetic trait?
4A woman with epilepsy on valproate wants to conceive. Which birth defect is her baby at highest risk of, and what reduces it?
5The MTHFR 677C>T variant raises NTD risk mainly by:
6A woman's previous pregnancy had a myelomeningocele. Recommended folic acid?
7When does the neural tube normally close?
8A couple has had two children with isolated cleft lip and palate. Recurrence risk for the next child?
9A child has cleft lip, hypertelorism, a short nose and small, hypoplastic fingernails. His mother takes an anticonvulsant for epilepsy. Most likely diagnosis?
10A child with cleft lip has a father with lower-lip pits and missing teeth. Gene and inheritance?
11A newborn has an encephalocele, polydactyly and polycystic kidneys. Recurrence risk for the parents?
12Both parents of a 30-year-old have type 2 diabetes. Her approximate lifetime risk?
| Item | In-house | Correct / Step 1 |
|---|---|---|
| Encephalocele | Slide: "herniation of the brain through the spine" | Herniation through a skull defect |
| DM2 gene | Slide: "CF7L2" | TCF7L2 |
| van der Woude | "Variable expressivity / penetrance 100%" | Variable expressivity with high (incomplete, ≈90%+) penetrance |
| Single-gene frequency | Slide 1/500–1/100; class notes 0.2–1% | Same range, written two ways |
| DM2 share | 80–90% (one slide) vs 90–95% (CDC slide) | ≈90–95% |